Literature DB >> 23386123

Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island.

Biju Bhargavan1, Bhavana Chhunchha, Nigar Fatma, Eri Kubo, Anil Kumar, Dhirendra P Singh.   

Abstract

Expression level of lens epithelial derived growth factor (LEDGF) is vital for LEDGF-mediated cell survival and cytoprotection against proapoptotic stimuli. We previously demonstrated that LEDGF is transcriptionally regulated by Sp1-responsive elements within a CpG island in the LEDGF promoter. Herein, we report on the existence of epigenetic signaling involved in the repression of LEDGF transcription in lens epithelial cells (LECs) facing UVB. UVB exposure led to histone H3 dimethylation and deacetylation at its CpG island, where a histone deacetylase/histone methylase (HDAC1/SUV39H1) complex was recruited. Exposure of LECs to UVB stress altered LEDGF protein and mRNA expression as well as promoter activity, while failing to methylate the CpG island. These events were correlated with increased reactive oxygen species (ROS) and increased cell death. LEDGF promoter activity and expression remained unaltered after 5-Aza treatment, but were relieved with tricostatin A, an inhibitor of HDACs. Expression analysis disclosed that UVB radiation altered the global expression levels of acetylated histone proteins, diminished total histone acetyltransferase (HAT) activity and increased HDAC activity and HDAC1 expression. In silico analysis of LEDGF proximal promoter and ChIP analyses disclosed HDAC1/SUV39H1 complex anchored to the -170/-10 nt promoter regions at Sp1-responsive elements and also attenuated Sp1 binding, resulting in HDAC1- and SUV39H1-dependent deacetylation and dimethylation of H3 at K9. Acetylation of H3K9 was essential for LEDGF active transcription, while enrichment of H3K9me2 at Sp1-responsive elements within CpGs (-170/-10) by UVB radiation repressed LEDGF transcription. Our study may contribute to understanding diseases associated with LEDGF aberrant expression due to specific epigenetic modifications, including blinding disorders.

Entities:  

Keywords:  DNA methyltransferase; LEDGE; Sp1; epigenetics; histone acetyltransferases; histone deacetylase; transcription

Mesh:

Substances:

Year:  2013        PMID: 23386123      PMCID: PMC3669119          DOI: 10.4161/epi.23861

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  77 in total

Review 1.  The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation?

Authors:  I Stec; S B Nagl; G J van Ommen; J T den Dunnen
Journal:  FEBS Lett       Date:  2000-05-04       Impact factor: 4.124

Review 2.  Review: Oxidative stress and disease.

Authors:  A Spector
Journal:  J Ocul Pharmacol Ther       Date:  2000-04       Impact factor: 2.671

3.  Partitioning and plasticity of repressive histone methylation states in mammalian chromatin.

Authors:  Antoine H F M Peters; Stefan Kubicek; Karl Mechtler; Roderick J O'Sullivan; Alwin A H A Derijck; Laura Perez-Burgos; Alexander Kohlmaier; Susanne Opravil; Makoto Tachibana; Yoichi Shinkai; Joost H A Martens; Thomas Jenuwein
Journal:  Mol Cell       Date:  2003-12       Impact factor: 17.970

4.  Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin.

Authors:  Goedele N Maertens; Peter Cherepanov; Alan Engelman
Journal:  J Cell Sci       Date:  2006-05-30       Impact factor: 5.285

Review 5.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  DNA binding domains and nuclear localization signal of LEDGF: contribution of two helix-turn-helix (HTH)-like domains and a stretch of 58 amino acids of the N-terminal to the trans-activation potential of LEDGF.

Authors:  Dhirendra P Singh; E Kubo; Y Takamura; T Shinohara; A Kumar; Leo T Chylack; N Fatma
Journal:  J Mol Biol       Date:  2005-11-09       Impact factor: 5.469

7.  Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation.

Authors:  H Ge; Y Si; R G Roeder
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

8.  Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.

Authors:  Jill A Fahrner; Sayaka Eguchi; James G Herman; Stephen B Baylin
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

9.  Transcriptional protein Sp1 regulates LEDGF transcription by directly interacting with its cis-elements in GC-rich region of TATA-less gene promoter.

Authors:  Dhirendra P Singh; Biju Bhargavan; Bhavana Chhunchha; Eri Kubo; Anil Kumar; Nigar Fatma
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

10.  LEDGF gene silencing impairs the tumorigenicity of prostate cancer DU145 cells by abating the expression of Hsp27 and activation of the Akt/ERK signaling pathway.

Authors:  B Bhargavan; N Fatma; B Chhunchha; V Singh; E Kubo; D P Singh
Journal:  Cell Death Dis       Date:  2012-05-31       Impact factor: 8.469

View more
  8 in total

Review 1.  Age-related cataracts: Role of unfolded protein response, Ca2+ mobilization, epigenetic DNA modifications, and loss of Nrf2/Keap1 dependent cytoprotection.

Authors:  Palsamy Periyasamy; Toshimichi Shinohara
Journal:  Prog Retin Eye Res       Date:  2017-08-31       Impact factor: 21.198

2.  Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene.

Authors:  Jenny Leitz; Miriam Reuschenbach; Claudia Lohrey; Anja Honegger; Rosita Accardi; Massimo Tommasino; Manuel Llano; Magnus von Knebel Doeberitz; Karin Hoppe-Seyler; Felix Hoppe-Seyler
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

Review 3.  The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.

Authors:  Robert L Ochs; Michael Mahler; Anamika Basu; Leslimar Rios-Colon; Tino W Sanchez; Luis E Andrade; Marvin J Fritzler; Carlos A Casiano
Journal:  Clin Exp Med       Date:  2015-06-19       Impact factor: 3.984

4.  Ultraviolet-B induces ERCC6 repression in lens epithelium cells of age-related nuclear cataract through coordinated DNA hypermethylation and histone deacetylation.

Authors:  Yong Wang; Fei Li; Guowei Zhang; Lihua Kang; Huaijin Guan
Journal:  Clin Epigenetics       Date:  2016-05-26       Impact factor: 6.551

5.  FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.

Authors:  Eri Kubo; Shinsuke Shibata; Teppei Shibata; Etsuko Kiyokawa; Hiroshi Sasaki; Dhirendra P Singh
Journal:  J Cell Mol Med       Date:  2016-12-15       Impact factor: 5.310

6.  Role of Decorin in Posterior Capsule Opacification and Eye Lens Development.

Authors:  Shinsuke Shibata; Naoko Shibata; Satoshi Ohtsuka; Yasuo Yoshitomi; Etsuko Kiyokawa; Hideto Yonekura; Dhirendra P Singh; Hiroshi Sasaki; Eri Kubo
Journal:  Cells       Date:  2021-04-09       Impact factor: 6.600

7.  Sulforaphane-induced transcription of thioredoxin reductase in lens: possible significance against cataract formation.

Authors:  Shambhu D Varma; Krish Chandrasekaran; Svitlana Kovtun
Journal:  Clin Ophthalmol       Date:  2013-10-24

8.  Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.

Authors:  Juliet D French; Sharon E Johnatty; Yi Lu; Jonathan Beesley; Bo Gao; Murugan Kalimutho; Michelle J Henderson; Amanda J Russell; Siddhartha Kar; Xiaoqing Chen; Kristine M Hillman; Susanne Kaufmann; Haran Sivakumaran; Martin O'Reilly; Chen Wang; Darren J Korbie; Diether Lambrechts; Evelyn Despierre; Els Van Nieuwenhuysen; Sandrina Lambrechts; Ignace Vergote; Beth Karlan; Jenny Lester; Sandra Orsulic; Christine Walsh; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Alexander Hein; Keitaro Matsuo; Satoyo Hosono; Jacobus Pisterer; Peter Hillemanns; Toru Nakanishi; Yasushi Yatabe; Marc T Goodman; Galina Lurie; Rayna K Matsuno; Pamela J Thompson; Tanja Pejovic; Yukie Bean; Florian Heitz; Philipp Harter; Andreas du Bois; Ira Schwaab; Estrid Hogdall; Susanne K Kjaer; Allan Jensen; Claus Hogdall; Lene Lundvall; Svend Aage Engelholm; Bob Brown; James M Flanagan; Michelle D Metcalf; Nadeem Siddiqui; Thomas Sellers; Brooke Fridley; Julie Cunningham; Joellen M Schildkraut; Ed Iversen; Rachel Palmieri Weber; Donal Brennan; Andrew Berchuck; Paul Pharoah; Paul Harnett; Murray D Norris; Michelle Haber; Ellen L Goode; Jason S Lee; Kum Kum Khanna; Kerstin B Meyer; Georgia Chenevix-Trench; Anna deFazio; Stacey L Edwards; Stuart MacGregor
Journal:  Oncotarget       Date:  2016-02-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.